Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States

Southern Medical Journal

Volumn 95, Issue 4, 2002, Pages 414-420

  Reichler, Mary R ^a   Reves, Randall ^a   Bur, Sarah ^a   Ford, Josie ^a   Thompson, Virginia ^a   Mangura, Bonita ^a   Onorato, Ida M ^a   Valway, Sarah E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DATA ANALYSIS; DISEASE TRANSMISSION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; SEROCONVERSION; SKIN TEST; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 0036214918     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200295040-00009     Document Type: Article

References (24)

1. Control of tuberculosis in the United States
2. The use of preventive therapy for tuberculous infection in the United States: Recommendations of the Advisory Committee for Elimination of Tuberculosis
3. Screening for tuberculosis and tuberculous infection in high-risk populations: Recommendations of the Advisory Committee for Elimination of Tuberculosis
4. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994
5. Contact tracing
6. The efficacy of varying durations of isonizaid preventive therapy for tuberculosis: Five years of follow-up in the International Union Against Tuberculosis trial
7. Isoniazid prophylaxis among Alaskan Eskimos: A final report of the Bethel isoniazid studies
8. Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy
9. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations
10. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus
11. A randomized trial of 2 months of rifampin (RIF) and pyrazinamide (PZA) versus 12 months of isoniazid (INH) for the prevention of tuberculosis (TB) in HIV-positive (+), PPD+ patients (PTS)
12. Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
13. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
14. An evaluation of investigations conducted to detect and prevent transmission of tuberculosis
15. Targeted tuberculin testing and treatment of latent tuberculosis infection
16. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli
17. Contacts of cases of active pulmonary tuberculosis
18. Establishing priority during investigation of tuberculosis contacts
19. Outcomes of contact investigations of infectious tuberculosis patients
20. Treatment of tuberculosis and tuberculosis infection in adults and children
21. Tuberculosis in New York City - Turning the tide
22. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis
23. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001